−0.1472SEK
−18.35 MSEK
177.36 M
About EUROCINE VACCINES AB
Sector
CEO
Hans Arwidsson
Headquarters
Solna
Website
Employees (FY)
3
Founded
1999
ISIN
SE0015382155
FIGI
BBG001Y25S35
Eurocine Vaccines AB engages in the research and development of nasal influenza vaccine for children and adult. Its technology, Endocine used to develop a patent protected nasal influenza vaccine for children. The company was founded in 1999 and is headquartered in Solna, Sweden.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of EUCI is 0.0596 SEK — it has decreased by 9.70% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NGM exchange EUROCINE VACCINES AB stocks are traded under the ticker EUCI.
EUCI stock is 39.58% volatile and has beta coefficient of 1.41. Check out the list of the most volatile stocks — is EUROCINE VACCINES AB there?
Yes, you can track EUROCINE VACCINES AB financials in yearly and quarterly reports right on TradingView.
EUCI stock has risen by 18.73% compared to the previous week, the month change is a 259.04% rise, over the last year EUROCINE VACCINES AB has showed a 94.73% decrease.
EUCI net income for the last quarter is −6.74 M SEK, while the quarter before that showed −2.02 M SEK of net income which accounts for −233.48% change. Track more EUROCINE VACCINES AB financial stats to get the full picture.
Today EUROCINE VACCINES AB has the market capitalization of 12.67 M, it has increased by 235.29% over the last week.
No, EUCI doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, EUCI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade EUROCINE VACCINES AB stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 25, 2024, the company has 3.00 employees. See our rating of the largest employees — is EUROCINE VACCINES AB on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So EUROCINE VACCINES AB technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating EUROCINE VACCINES AB stock shows the sell signal. See more of EUROCINE VACCINES AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.